orforglipron vs oral semaglutide ACHIEVE-3 results: Lilly's Orfoglipron performance shows superior weight loss, blood sugar control in head-to-head trial with : r/tirzepatidecompound Orforglipron vs Oral Semaglutide 25

This is an inference from the categorys current growth, not evidence that GLP-1 users prefer RTDs

Luijten 1 , Lotte Haverman 1 1 Amsterdam UMC location University of Amsterdam, Emma Childrens Hospital, Child and Adolescent Psychiatry & Psychosocial Care, Meibergdreef 9, Amsterdam, The Netherlands, 2 UMC Utrecht Brain Center, University Medical Center Utrecht, The Netherlands, 3 De Hoogstraat Rehabilitation, Utrecht, Center of Excellence for Rehabilitation Medicine Utrecht, The Netherlands, 4 CAPHRI, Maastricht University, Maastricht, the Netherlands, 5 Centre of Expertise, Adelante Rehabilitation centre, Valkenburg, the Netherlands, 6 Rehabilitation Science and Physiotherapy, REVAL, Hasselt University, Belgium, Maastricht, Netherlands, 7 Research Group Moving, Growing and Thriving Together, HU University of Applied Sciences, Utrecht, The Netherlands Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :VP4 Aims While self-reported patient-reported outcome measures (PROMs) are preferred, proxies are sometimes necessary

This drop can lead to increased body fat, poor sleep, slower recovery, and a noticeable decrease in motivation

H302 : Harmful if swallowed

It is not for human consumption, and dosing instructions are not provided

Based on semaglutide trials, Eli Lilly expects a 5 to 7% body weight loss at this time point